← Back to Search

Trauma-focused Intervention for HIV

N/A
Recruiting
Led By Monique J Brown, PhD, MPH
Research Sponsored by University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
50 years old or older
<100 % ART adherence
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial is investigating whether two interventions, LIFT and REFLECT, can help older adults living with HIV who experienced childhood sexual abuse.

Who is the study for?
This trial is for older adults who are at least 50 years old, living with HIV, and have experienced childhood sexual abuse. They should be less than fully adherent to antiretroviral therapy (ART) and exhibit depressive symptoms.Check my eligibility
What is being tested?
The study is testing a new intervention called CoSHA which stands for Coping with childhood Sexual Abuse, HIV, and Aging. It's being compared to a control group without this specific intervention. The focus is on adapting existing therapies to better suit the needs of older adults with HIV.See study design
What are the potential side effects?
Since this trial involves psychological interventions rather than medications, traditional side effects are not expected. Participants may experience emotional discomfort or distress when discussing past trauma.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 50 years old or older.
Select...
I have not fully adhered to my ART medication.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
ART adherence
Secondary outcome measures
Health-related quality of life
Other outcome measures
Depressive symptoms

Trial Design

2Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
Group II: ControlExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Control
2011
Completed Phase 4
~15780

Find a Location

Who is running the clinical trial?

University of South CarolinaLead Sponsor
211 Previous Clinical Trials
120,419 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,786 Previous Clinical Trials
2,689,727 Total Patients Enrolled
Monique J Brown, PhD, MPHPrincipal InvestigatorUniversity of South Carolina

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any specific requirements for joining this clinical experiment?

"Patient eligibility for this trial requires that they be HIV positive, between 50 and 85 years of age, have <100% ART adherence, and are suffering from depressive symptoms. 40 individuals will be admitted in total."

Answered by AI

Are applications for this clinical trial currently being accepted?

"Clinicaltrials.gov corroborates that this study is currently seeking participants, with the trial first posted on January 18th 2022 and last updated March 10th 2022."

Answered by AI

How extensive is the participant pool for this experiment?

"Indeed, the details available on clinicaltrials.gov verify that this medical research is presently recruiting participants. The study was initially posted on January 18th 2022 and revised most recently on March 10th 2022; it seeks to enrol 40 patients from a single centre."

Answered by AI

Is the age criterion for this study limited to persons below 25 years old?

"This clinical trial is accepting individuals aged 50-85. Subsequently, there are 152 trials for minors and 909 for seniors."

Answered by AI
~1 spots leftby May 2024